We have an updated report [Version - 2024] available. Kindly sign up to get the sample of the report.
all report title image

GLOBAL ENTERAL FEEDING FORMULAS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2023 - 2030)

Global Enteral Feeding Formulas Market, By Product (Standard Formula, Disease-specific Formulas, Elemental Formulas, Specialized Formulas), By Flow Type (Intermittent Feeding Flow, Continuous Feeding Flow), By Stage (Adults, Pediatrics), By Indication (Alzheimer’s, Nutrition Deficiency, Cancer Care, Diabetes, Chronic Kidney Diseases, Orphan Diseases, Dysphagia, Pain Management, Others (Malabsorption/GI Disorder/Diarrhea, etc.)), By End Use (Hospitals (Cardiology, Neurology, Critical Care (ICU), Oncology, Others), Home Care), By Sales Channel (Online Sales, Retail Sales, Institutional Sales), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

  • Published In : Dec 2023
  • Code : CMI6515
  • Pages :175
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical

Market News

Global Enteral Feeding Formulas Market- Recent Developments

Business Development Activities by the Market Players

  • On September 28, 2023, Cardinal Health, a U.S.-based multinational health care services company, announced the Kangaroo OMNI Enteral Feeding Pump in the US. This innovative pump is designed to offer more options for enteral feeding patients, catering to their personalized needs throughout the enteral feeding journey. This launch signifies Cardinal Health's commitment to enhancing the options available for patients undergoing enteral feeding, providing a more tailored and flexible approach to their medical care.
  • On September 18, 2023, Vonco Products LLC, a prominent risk-free plastic and packaging manufacturer, reported that the U.S. Food and Drug Administration (FDA) has granted clearance for EnteraLoc Flow as an over-the-counter (OTC) direct-connect feeding solution for enteral patients. This regulatory approval reflects a significant milestone for Vonco Products, enabling broader accessibility to EnteraLoc Flow and enhancing options for enteral patients seeking feeding solutions.
  • In May 2022, Abbott, a U.S.-based multinational medical devices and health care company, announced that the U.S. District Court for the Western District of Michigan has modified the recent consent decree, enabling the release of restricted quantities of its EleCare specialty amino acid-based formulas. This decision follows the recall of certain powder infant formulas from Abbott's Sturgis, Michigan, U.S., facility on February 17, 2022. The amendment allows for the distribution of EleCare products that were temporarily withheld, addressing concerns related to the recal

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.